AU2020315931A1 - Polynucleotides for the amplification and detection of Neisseria gonorrhoeae - Google Patents

Polynucleotides for the amplification and detection of Neisseria gonorrhoeae Download PDF

Info

Publication number
AU2020315931A1
AU2020315931A1 AU2020315931A AU2020315931A AU2020315931A1 AU 2020315931 A1 AU2020315931 A1 AU 2020315931A1 AU 2020315931 A AU2020315931 A AU 2020315931A AU 2020315931 A AU2020315931 A AU 2020315931A AU 2020315931 A1 AU2020315931 A1 AU 2020315931A1
Authority
AU
Australia
Prior art keywords
seq
sequence
composition
nucleotides
amplification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020315931A
Other languages
English (en)
Inventor
Andrea C. Dedent
Hédia MAAMAR
Dana Kelly VANATTA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Talis Biomedical Corp
Original Assignee
Talis Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Talis Biomedical Corp filed Critical Talis Biomedical Corp
Publication of AU2020315931A1 publication Critical patent/AU2020315931A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00Reactions of nucleic acids characterised by
    • C12Q2531/10Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/119Strand displacement amplification [SDA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2020315931A 2019-07-25 2020-07-24 Polynucleotides for the amplification and detection of Neisseria gonorrhoeae Abandoned AU2020315931A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962878639P 2019-07-25 2019-07-25
US62/878,639 2019-07-25
US201916523609A 2019-07-26 2019-07-26
US16/523,609 2019-07-26
US16/719,744 2019-12-18
US16/719,744 US10954572B2 (en) 2019-07-25 2019-12-18 Polynucleotides for the amplification and detection of Neisseria gonorrhoeae
PCT/US2020/043620 WO2021016602A1 (en) 2019-07-25 2020-07-24 Polynucleotides for the amplification and detection of neisseria gonorrhoeae

Publications (1)

Publication Number Publication Date
AU2020315931A1 true AU2020315931A1 (en) 2022-03-03

Family

ID=74190742

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020315931A Abandoned AU2020315931A1 (en) 2019-07-25 2020-07-24 Polynucleotides for the amplification and detection of Neisseria gonorrhoeae

Country Status (15)

Country Link
US (1) US10954572B2 (https=)
EP (1) EP4004014A4 (https=)
JP (1) JP2022542361A (https=)
KR (1) KR20220044760A (https=)
CN (1) CN114502747A (https=)
AU (1) AU2020315931A1 (https=)
BR (1) BR112022001038A2 (https=)
CA (1) CA3147244A1 (https=)
CL (1) CL2022000126A1 (https=)
CO (1) CO2022001223A2 (https=)
IL (1) IL289461A (https=)
JO (1) JOP20220004A1 (https=)
MX (1) MX2022000907A (https=)
PH (1) PH12022550060A1 (https=)
WO (1) WO2021016602A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110177887B (zh) 2016-11-10 2024-10-29 达丽斯生物医学公司 用于扩增和检测沙眼衣原体的多核苷酸
US11008627B2 (en) * 2019-08-15 2021-05-18 Talis Biomedical Corporation Diagnostic system
US11891662B2 (en) 2019-12-02 2024-02-06 Talis Biomedical Corporation Polynucleotides for amplification and detection of human beta actin
US11047007B1 (en) 2020-03-23 2021-06-29 Talis Biomedical Corporation Polynucleotides for amplification and detection of SARS-CoV-2
PL437280A1 (pl) * 2021-03-12 2022-09-19 Genomtec Spółka Akcyjna Zestaw starterów do powielania, sposób wykrywania infekcji bakteryjnej przenoszonej drogą płciową oraz zestaw do wykrywania infekcji
EP4388092A1 (en) * 2021-08-18 2024-06-26 Talis Biomedical Corporation Polynucleotides for the amplification and detection of influenza a
CN114959081B (zh) * 2022-06-08 2025-07-25 河北三狮生物科技有限公司 一种LAMP-Taqman检测鸡毒支原体的引物和探针及其应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234809A (en) 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
US5155018A (en) 1991-07-10 1992-10-13 Hahnemann University Process and kit for isolating and purifying RNA from biological sources
DE4321904B4 (de) 1993-07-01 2013-05-16 Qiagen Gmbh Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen
US5514551A (en) 1994-10-14 1996-05-07 Gen-Probe Incorporated Compositions for the detection of Chlamydia trachomatis
EP0866071B1 (en) 1997-03-20 2004-10-20 F. Hoffmann-La Roche Ag Modified primers
US7572902B2 (en) 1997-12-09 2009-08-11 Monsanto Technology Llc Nucleic acid molecules seq id No. 16372 and other molecules associated with plants
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
US7807802B2 (en) * 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
JP4410268B2 (ja) 2007-03-28 2010-02-03 株式会社東芝 メチレンテトラヒドロ葉酸還元酵素(mthfr)の遺伝子型を検出するための核酸プライマーセット及び核酸プローブ
JP5619602B2 (ja) 2007-04-13 2014-11-05 アボツト・モレキユラー・インコーポレイテツド クラミジア・トラコマチスを検出するためのプライマー及びプローブ配列
JP5313157B2 (ja) 2007-10-19 2013-10-09 栄研化学株式会社 核酸増幅法、それに用いる試薬及び試薬キット
CN101831488A (zh) 2009-03-11 2010-09-15 孙星江 利用环介导等温扩增技术快速检测淋病奈瑟菌
GB0922097D0 (en) 2009-12-17 2010-02-03 Atlas Genetics Ltd Microbial assay
CN101886122B (zh) 2010-05-10 2012-10-17 珠海市银科医学工程有限公司 环介导恒温扩增检测肺炎衣原体的方法及检测试剂盒
EP2388312A1 (en) 2010-05-17 2011-11-23 Curetis AG Universally applicable lysis buffer and processing methods for the lysis of bodily samples
WO2012054588A2 (en) 2010-10-22 2012-04-26 T2 Biosystems, Inc. Conduit-containing devices and methods for analyte processing and detection
JP2012085605A (ja) 2010-10-22 2012-05-10 Sony Corp 核酸増幅反応装置、核酸増幅反応装置に用いる基板、及び核酸増幅反応方法
US20130017539A1 (en) 2011-07-11 2013-01-17 Program For Appropriate Technology In Health Methods and compositions for chlamydia trachomatis diagnostic testing
US10876160B2 (en) 2011-10-31 2020-12-29 Eiken Kagaku Kabushiki Kaisha Method for detecting target nucleic acid
WO2014025337A1 (en) 2012-08-06 2014-02-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Methods and reagents for amplifying nucleic acids
US20140114215A1 (en) 2012-10-20 2014-04-24 Medtronic Ardian Luxembourg S.A.R.L. Methods for Renal Neuromodulation and Associated Systems and Devices
WO2014064002A1 (en) 2012-10-22 2014-05-01 Bayer Cropscience Nv Methods, compositions and devices for amplification of nucleic acids
AU2014237563B2 (en) * 2013-03-15 2020-06-11 Becton, Dickinson And Company Detection of neisseria gonorrhoeaes
WO2015013676A1 (en) 2013-07-26 2015-01-29 Cepheid Methods of detecting chlamydia and gonorrhea and of screening for infection/inflammation based on genomic copy number
EP3058100A4 (en) 2013-10-18 2017-04-19 California Institute of Technology Enhanced nucleic acid identification and detection
GB201319180D0 (en) * 2013-10-30 2013-12-11 Mast Group Ltd Nucleic acid probe
US10364458B2 (en) 2014-07-16 2019-07-30 Tangen Biosciences, Inc. Isothermal methods for amplifying nucleic acid samples
KR20180040511A (ko) 2014-11-05 2018-04-20 캘리포니아 인스티튜트 오브 테크놀로지 유기체의 약물에 대한 반응의 미세유체 측정
US10227661B2 (en) 2014-11-21 2019-03-12 GeneWeave Biosciences, Inc. Sequence-specific detection and phenotype determination
US20190111423A1 (en) * 2014-12-23 2019-04-18 California Institute Of Technology Devices and methods for autonomous measurements
US9657353B2 (en) 2015-06-26 2017-05-23 Great Basin Scientific, Inc. Specific detection of organisms derived from a sample
AU2017261283B2 (en) 2016-05-04 2023-02-09 Children's Hospital & Research Center At Oakland Rapid extraction of nucleic acids from clinical samples for downstream applications
CN110225919A (zh) 2016-11-10 2019-09-10 达丽斯生物医学公司 用于扩增和检测淋病奈瑟氏菌的多核苷酸
CN110177887B (zh) 2016-11-10 2024-10-29 达丽斯生物医学公司 用于扩增和检测沙眼衣原体的多核苷酸
WO2018089943A1 (en) 2016-11-10 2018-05-17 Slipchip Corporation Probe detection of loop-mediated amplification products
CN107099618A (zh) 2017-05-03 2017-08-29 上海速创诊断产品有限公司 一种用于检测泌尿生殖道致病微生物的lamp引物组合物及其相关应用
US10450616B1 (en) 2018-05-09 2019-10-22 Talis Biomedical Corporation Polynucleotides for the amplification and detection of Chlamydia trachomatis

Also Published As

Publication number Publication date
JOP20220004A1 (ar) 2023-01-30
US20210024980A1 (en) 2021-01-28
CA3147244A1 (en) 2021-01-28
CO2022001223A2 (es) 2022-03-08
MX2022000907A (es) 2022-02-16
PH12022550060A1 (en) 2023-04-12
CN114502747A (zh) 2022-05-13
US10954572B2 (en) 2021-03-23
CL2022000126A1 (es) 2022-11-11
EP4004014A1 (en) 2022-06-01
KR20220044760A (ko) 2022-04-11
JP2022542361A (ja) 2022-10-03
IL289461A (en) 2022-02-01
EP4004014A4 (en) 2023-09-13
BR112022001038A2 (pt) 2022-03-15
WO2021016602A1 (en) 2021-01-28

Similar Documents

Publication Publication Date Title
US10954572B2 (en) Polynucleotides for the amplification and detection of Neisseria gonorrhoeae
US20230073971A1 (en) Polynucleotides for the Amplification and Detection of Chlamydia Trachomatis
US20240117447A1 (en) Polynucleotides for the amplification and detection of neisseria gonorrhoeae
US12275999B2 (en) Polynucleotides for the amplification and detection of chlamydia trachomatis
US11047007B1 (en) Polynucleotides for amplification and detection of SARS-CoV-2
US20240026465A9 (en) Polynucleotides for the amplification and detection of neisseria gonorrhoeae
WO2021113267A1 (en) Polynucleotides for the amplification and detection of human beta actin
HK40074327A (en) Polynucleotides for the amplification and detection of neisseria gonorrhoeae
WO2023023595A1 (en) Polynucleotides for the amplification and detection of influenza b
HK40013680A (en) Polynucleotides for the amplification and detection of neisseria gonorrhoeae
HK40013464A (en) Polynucleotides for the amplification and detection of chlamydia trachomatis

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application